27.91
price down icon0.04%   -0.01
after-market Handel nachbörslich: 28.00 0.09 +0.32%
loading

Immunocore Holdings Plc Adr Aktie (IMCR) Neueste Nachrichten

pulisher
Apr 25, 2026

Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat

Apr 25, 2026
pulisher
Apr 24, 2026

Immunocore (IMCR) upgraded to strong buy: Here's why - MSN

Apr 24, 2026
pulisher
Apr 22, 2026

Q1 Earnings Forecast for Immunocore Issued By HC Wainwright - MarketBeat

Apr 22, 2026
pulisher
Apr 19, 2026

KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma - GlobeNewswire Inc.

Apr 19, 2026
pulisher
Apr 17, 2026

Massachusetts Financial Services Co. MA Trims Holdings in Immunocore Holdings PLC Sponsored ADR $IMCR - MarketBeat

Apr 17, 2026
pulisher
Apr 16, 2026

Immunocore (NASDAQ: IMCR) outlines 10 resolutions for 2026 hybrid AGM - Stock Titan

Apr 16, 2026
pulisher
Apr 15, 2026

H.C. Wainwright reiterates Immunocore stock rating citing KIMMTRAK penetration - Investing.com

Apr 15, 2026
pulisher
Apr 14, 2026

Immunocore Details KIMMTRAK Growth, TCR Platform and Key Readouts at Needham Conference - Yahoo Finance

Apr 14, 2026
pulisher
Apr 08, 2026

Immunocore Holdings Plc (NASDAQ: IMCR) plans same‑day cashless sale of 25,000 ADRs - Stock Titan

Apr 08, 2026
pulisher
Apr 07, 2026

Immunocore Holdings stock: What you need to know for smart investing now - AD HOC NEWS

Apr 07, 2026
pulisher
Apr 06, 2026

Immunocore Holdings plc (IMCR) stock price, news, quote and history - uk.finance.yahoo.com

Apr 06, 2026
pulisher
Apr 01, 2026

Immunocore Holdings stock: Precision Oncology Leader with ImmTAC Innovation - AD HOC NEWS

Apr 01, 2026
pulisher
Mar 31, 2026

Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat

Mar 31, 2026
pulisher
Mar 31, 2026

Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Short Interest Down 15.4% in March - MarketBeat

Mar 31, 2026
pulisher
Mar 23, 2026

Jefferies reiterates Hold on Immunocore stock amid competitor data By Investing.com - Investing.com South Africa

Mar 23, 2026
pulisher
Mar 23, 2026

Jefferies reiterates Hold on Immunocore stock amid competitor data - Investing.com

Mar 23, 2026
pulisher
Mar 21, 2026

IMCR SEC FilingsImmunocore Holdings Plc 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 21, 2026
pulisher
Mar 17, 2026

Immunocore (IMCR) upgraded to strong buy: Here's what you should know - MSN

Mar 17, 2026
pulisher
Mar 16, 2026

Jefferies downgrades Immunocore stock rating on revenue concerns - Investing.com

Mar 16, 2026
pulisher
Mar 16, 2026

Jefferies downgrades Immunocore stock rating on revenue concerns By Investing.com - Investing.com South Africa

Mar 16, 2026
pulisher
Mar 11, 2026

Insider sells 11,832 ADRs at Immunocore (NASDAQ: IMCR) in cashless exercise - Stock Titan

Mar 11, 2026
pulisher
Mar 09, 2026

Immunocore at Leerink Conference: Strategic Growth and Innovation - Investing.com

Mar 09, 2026
pulisher
Mar 06, 2026

What is HC Wainwright's Estimate for Immunocore Q1 Earnings? - MarketBeat

Mar 06, 2026
pulisher
Mar 06, 2026

Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Mar 06, 2026
pulisher
Mar 06, 2026

T. Rowe Price (IMCR) lists 3,041,904 ADRs, a 6.0% stake in Immunocore - stocktitan.net

Mar 06, 2026
pulisher
Mar 05, 2026

FY2027 EPS Estimates for Immunocore Cut by HC Wainwright - MarketBeat

Mar 05, 2026
pulisher
Feb 27, 2026

Immunocore (NASDAQ:IMCR) Price Target Raised to $75.00 at Needham & Company LLC - Defense World

Feb 27, 2026
pulisher
Feb 25, 2026

Immunocore Q4 Earnings Call Highlights - Yahoo Finance

Feb 25, 2026
pulisher
Feb 25, 2026

Immunocore Holdings earnings missed by $0.40, revenue fell short of estimates - Investing.com South Africa

Feb 25, 2026
pulisher
Feb 25, 2026

RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up - Finviz

Feb 25, 2026
pulisher
Feb 25, 2026

JAZZ Stock Rises as Q4 Earnings & Sales Top Expectations - Finviz

Feb 25, 2026
pulisher
Feb 25, 2026

Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y - Finviz

Feb 25, 2026
pulisher
Feb 25, 2026

Apellis Q4 Loss Wider Than Expected, Revenues Decline Y/Y - Finviz

Feb 25, 2026
pulisher
Feb 25, 2026

Earnings call transcript: Immunocore Holdings Q4 2025 reveals strong growth, stock dips By Investing.com - Investing.com South Africa

Feb 25, 2026
pulisher
Feb 25, 2026

Earnings call transcript: Immunocore Holdings Q4 2025 reveals strong growth, stock dips - Investing.com India

Feb 25, 2026
pulisher
Feb 24, 2026

Immunocore earnings ahead as melanoma pipeline advances By Investing.com - Investing.com India

Feb 24, 2026
pulisher
Feb 24, 2026

Immunocore earnings ahead as melanoma pipeline advances - Investing.com

Feb 24, 2026
pulisher
Feb 20, 2026

Madrigal Q4 Earnings Miss, MASH Drug Sales Drive Top Line, Stock Down - Finviz

Feb 20, 2026
pulisher
Feb 19, 2026

Immunocore (NASDAQ:IMCR) CAO John Goll Sells 698 Shares - MarketBeat

Feb 19, 2026
pulisher
Feb 19, 2026

Leger Tina Amber St Sells 1,000 Shares of Immunocore (NASDAQ:IMCR) Stock - MarketBeat

Feb 19, 2026
pulisher
Feb 19, 2026

Immunocore (NASDAQ:IMCR) CEO Bahija Jallal Sells 11,474 Shares - MarketBeat

Feb 19, 2026
pulisher
Feb 19, 2026

David Berman Sells 5,965 Shares of Immunocore (NASDAQ:IMCR) Stock - MarketBeat

Feb 19, 2026
pulisher
Feb 18, 2026

[144] Immunocore Holdings plc SEC Filing - Stock Titan

Feb 18, 2026
pulisher
Feb 17, 2026

Immunocore (IMCR) Upgraded to Strong Buy: Here's Why - Yahoo Finance

Feb 17, 2026
pulisher
Feb 14, 2026

Immunocore Q4 2025 Earnings Call Transcript - MarketBeat

Feb 14, 2026
pulisher
Feb 13, 2026

SNY Stock Falls After Board Suddenly Makes Leadership Change - Finviz

Feb 13, 2026
$28.53
price up icon 3.67%
$50.09
price up icon 1.21%
$103.45
price up icon 1.85%
$136.33
price up icon 0.96%
$144.12
price up icon 2.54%
ONC ONC
$295.27
price up icon 1.54%
Kapitalisierung:     |  Volumen (24h):